Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Julia A. Remizova"'
Autor:
Ivan B. Filippenkov, Julia A. Remizova, Alina E. Denisova, Vasily V. Stavchansky, Ksenia D. Golovina, Leonid V. Gubsky, Svetlana A. Limborska, Lyudmila V. Dergunova
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Ischemic stroke is one of the most severe polygenic brain diseases. Here, we performed further functional genetic analysis of the processes occurring in the contralateral hemisphere (CH) after ischemia–reperfusion injury in rat brain. Comp
Externí odkaz:
https://doaj.org/article/97ff7a1652614317b2bd0032f0d1a6ec
Autor:
Ivan B. Filippenkov, Julia A. Remizova, Vasily V. Stavchansky, Alina E. Denisova, Leonid V. Gubsky, Nikolay F. Myasoedov, Svetlana A. Limborska, Lyudmila V. Dergunova
Publikováno v:
Genes, Vol 14, Iss 7, p 1382 (2023)
Ischemic stroke is an acute local decrease in cerebral blood flow due to a thrombus or embolus. Of particular importance is the study of the genetic systems that determine the mechanisms underlying the formation and maintenance of a therapeutic windo
Externí odkaz:
https://doaj.org/article/ce9f00a3cf674f87b0345781aff7c708
Autor:
Vasily V. Stavchansky, Ivan B. Filippenkov, Julia A. Remizova, Alina E. Denisova, Ivan V. Mozgovoy, Leonid V. Gubsky, Nikolay F. Myasoedov, Lyudmila A. Andreeva, Svetlana A. Limborska, Lyudmila V. Dergunova
Publikováno v:
Genes, Vol 13, Iss 12, p 2380 (2022)
Glyprolines are Gly-Pro (GP)- or Pro-Gly (PG)-containing biogenic peptides. These peptides can act as neutrophil chemoattractants, or atheroprotective, anticoagulant, and neuroprotective agents. The Pro-Gly-Pro (PGP) tripeptide is an active factor of
Externí odkaz:
https://doaj.org/article/5656483858684539b1ed89ca78ee6f6f
Autor:
Ivan B. Filippenkov, Julia A. Remizova, Alina E. Denisova, Vasily V. Stavchansky, Ksenia D. Golovina, Leonid V. Gubsky, Svetlana A. Limborska, Lyudmila V. Dergunova
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 13, p 7308 (2022)
Ischemic stroke is a multifactorial disease with a complex etiology and global consequences. Model animals are widely used in stroke studies. Various controls, either brain samples from sham-operated (SO) animals or symmetrically located brain sample
Externí odkaz:
https://doaj.org/article/7991aceea65345c2a05590c21273e888
Autor:
Ivan B. Filippenkov, Vasily V. Stavchansky, Alina E. Denisova, Liya V. Valieva, Julia A. Remizova, Ivan V. Mozgovoy, Elizaveta I. Zaytceva, Leonid V. Gubsky, Svetlana A. Limborska, Lyudmila V. Dergunova
Publikováno v:
Genes, Vol 12, Iss 12, p 1870 (2021)
Ischemic brain stroke is one of the most serious and socially significant diseases. In addition to messenger RNAs (mRNAs), encoding protein, the study of regulatory RNAs in ischemic has exceptional importance for the development of new strategies for
Externí odkaz:
https://doaj.org/article/596199f317864ad1be44b94a055bd2f9
Autor:
Ivan B. Filippenkov, Vasily V. Stavchansky, Natalya Yu. Glazova, Elena A. Sebentsova, Julia A. Remizova, Liya V. Valieva, Natalia G. Levitskaya, Nikolai F. Myasoedov, Svetlana A. Limborska, Lyudmila V. Dergunova
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 18, p 10054 (2021)
Natural melanocortins (MCs) have been used in the successful development of drugs with neuroprotective properties. Here, we studied the behavioral effects and molecular genetic mechanisms of two synthetic MC derivatives-ACTH(4–7)PGP (Semax) and ACT
Externí odkaz:
https://doaj.org/article/c562a17b19f14caaabaa6d7f4ce8cb8c
Autor:
Olga Yu. Sudarkina, Ivan B. Filippenkov, Vasily V. Stavchansky, Alina E. Denisova, Vadim V. Yuzhakov, Larisa E. Sevan’kaeva, Liya V. Valieva, Julia A. Remizova, Veronika G. Dmitrieva, Leonid V. Gubsky, Nikolai F. Myasoedov, Svetlana A. Limborska, Lyudmila V. Dergunova
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 12, p 6179 (2021)
The Semax (Met-Glu-His-Phe-Pro-Gly-Pro) peptide is a synthetic melanocortin derivative that is used in the treatment of ischemic stroke. Previously, studies of the molecular mechanisms underlying the actions of Semax using models of cerebral ischemia
Externí odkaz:
https://doaj.org/article/aee42ef1bfe8425083ea7666d0c68a61
Autor:
Dergunova, Ivan B. Filippenkov, Julia A. Remizova, Vasily V. Stavchansky, Alina E. Denisova, Leonid V. Gubsky, Nikolay F. Myasoedov, Svetlana A. Limborska, Lyudmila V.
Publikováno v:
Genes; Volume 14; Issue 7; Pages: 1382
Ischemic stroke is an acute local decrease in cerebral blood flow due to a thrombus or embolus. Of particular importance is the study of the genetic systems that determine the mechanisms underlying the formation and maintenance of a therapeutic windo
Autor:
Svetlana A. Limborska, Olga Yu Sudarkina, Julia A Remizova, Veronika G Dmitrieva, Ivan B. Filippenkov, L.V. Dergunova, Liya V Valieva, Larisa E. Sevan’kaeva, Vadim V. Yuzhakov, Leonid V. Gubsky, N.F. Myasoedov, Vasily V Stavchansky, Alina E. Denisova
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 12
International Journal of Molecular Sciences, Vol 22, Iss 6179, p 6179 (2021)
Volume 22
Issue 12
International Journal of Molecular Sciences, Vol 22, Iss 6179, p 6179 (2021)
The Semax (Met-Glu-His-Phe-Pro-Gly-Pro) peptide is a synthetic melanocortin derivative that is used in the treatment of ischemic stroke. Previously, studies of the molecular mechanisms underlying the actions of Semax using models of cerebral ischemia